Search Results

Mirimus and Biogen, AavantiBio and Aldevron, Exscientia and GT Apeiron Therapeutics announced strategic partnerships this morning.

Mirimus, Inc. today announced a strategic collaboration with Biogen Inc. (NASDAQ: BIIB) focused on the development of RNAi-based therapeutics targeting multiple, undisclosed neurological disease indications.

Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced it has been named as one of five winners in XPRIZE Rapid COVID Testing for its pioneering SalivaClear™ COVID-19 pooled saliva testing platform.

Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced a partnership with Eckerd College, a private, coeducational college of liberal arts and sciences in St. Petersburg, Fla., to enable weekly COVID-19 surveillance testing of faculty, staff and students using its pioneering SalivaClear COVID-19 pooled saliva testing platform.

Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, announced that since October 2020 it has worked with The Pingry School, a K-12, o conduct COVID-19 surveillance testing of faculty, staff and students using its pioneering SalivaClear COVID-19 pooled saliva testing platform.

Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced the publication of a scientific paper, titled, “Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections in K-12 Schools and Universities,” available for preprint on MedRxiv as it undergoes scientific peer review for potential publication.

Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, announced a partnership with the Rotary Club of Chinatown to enable businesses operating in Manhattan’s Chinatown neighborhood to conduct weekly COVID-19 monitoring of their staff using its pioneering SalivaClear COVID-19 pooled saliva testing platform.

Mirimus’ SalivaClear monitored all players, coaches, tournament staff and internal media for SARS-CoV-2, with results provided within 24-hours of each pooled test More than 1,900 SalivaClear COVID-19 tests conducted during unprecedented 10-day basketball event

More than 8,000 Saliva Tests Performed Since Fall 2020 on 300+ Student Athletes, Coaches and Staff in 17 Sports

Detecting the presence of SARS-CoV-2 in asymptomatic individuals has been a challenge not even PCR – the gold standard of testing – can adequately address. Now two companies have developed novel solutions with the sensitivity and specificity needed to provide ample warning.